About the Company
at sutro biopharma we have pioneered a compelling and unique way of discovering, developing and manufacturing therapeutics. our focus is aimed primarily on next generation cancer therapeutics — antibody conjugates and bispecific antibodies. unconstrained by traditional methods of cell-based discovery, we can design and develop targeted medicines by innovating outside the constraints of the cell. our technology enables us to iteratively discover and test molecules in a rapid cycle of weeks rather than months, to rapidly identify the optimal molecule designed for safety and potency. our approach to discovery, without the cell, is also transcending the the limitations of biologics manufacturing. sutro has the world’s only cgmp cell-free manufacturing facility located in san carlos, california. this state-of- the-art facility confers an important competitive advantage as we head into human clinical trials in 2018. in addition to developing our own oncology pipeline, sutro biopharma is coll
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
260
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $STRO News
Sutro Biopharma, Inc. (STRO) Surges 9.5%: Is This an Indication of Further Gains?
Sutro Biopharma, Inc. is part of the Zacks Medical - Biomedical and Genetics industry. Anika Therapeutics ANIK, another stock in the same industry, closed the last trading session 0.6% lower at ...
Sutro Biopharma, Inc.
Sutro Biopharma Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was ...
San Francisco Residential Real Estate News
Shipping companies received awards for reducing speeds in the 2023 “Protecting Blue Whales & Blue Skies… Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the ...
Sutro Biopharma, Inc. (STRO) Surges 9.5%: Is This an Indication of Further Gains?
Sutro Biopharma, Inc. STRO shares rallied 9.5% in the last trading session to close at $5.26. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Sutro Biopharma Inc STRO
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Sutro Biopharma, Inc. (STRO) Surges 9.5%: Is This an Indication of Further Gains?
Sutro Biopharma, Inc. STRO shares rallied 9.5% in the last trading session to close at $5.26. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Sutro Biopharma Inc STRO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Sutro Biopharma, Inc. (STRO)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Loading the latest forecasts...